Katharina L. Dürr

Enabling mechanism-driven therapeutic discovery for challenging membrane protein targets

Membrane proteins drive cellular signalling, ion gradients and the transport of metabolites and nutrients; their dysregulation causes disease, and more than 50% of approved drugs act on them — yet many remain undrugged. We work out how they function and build the tools needed to target them, combining structural biology with mass spectrometry and generating high-quality protein binders by machine learning and classical design. We work with academic and industry partners worldwide.

Director of Translational Research, Kavli Institute for Nanoscience Discovery — Department of Chemistry, University of Oxford

Research highlights

Latest updates